These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy. Li L, Tian J, Long MK, Chen Y, Lu J, Zhou C, Wang T. PLoS One; 2016 Jul 03; 11(1):e0144219. PubMed ID: 26751695 [Abstract] [Full Text] [Related]
27. Hypoxic-ischemic damage and the neuroprotective effects of GM1 ganglioside. Leon A, Lipartiti M, Seren MS, Lazzaro A, Mazzari S, Koga T, Toffano G, Skaper SD. Stroke; 1990 Nov 03; 21(11 Suppl):III95-7. PubMed ID: 2237992 [Abstract] [Full Text] [Related]
28. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study. Simon RP, Chen J, Graham SH. J Pharmacol Exp Ther; 1993 Apr 03; 265(1):24-9. PubMed ID: 8474009 [Abstract] [Full Text] [Related]
29. GM1 ganglioside reduces ischemia-induced excitatory amino acid output: a microdialysis study in the gerbil hippocampus. Lombardi G, Moroni F. Neurosci Lett; 1992 Jan 06; 134(2):171-4. PubMed ID: 1589143 [Abstract] [Full Text] [Related]
30. Neutrophil as a mediator of ischemic edema formation in the brain. Shiga Y, Onodera H, Kogure K, Yamasaki Y, Yashima Y, Syozuhara H, Sendo F. Neurosci Lett; 1991 Apr 29; 125(2):110-2. PubMed ID: 1881586 [Abstract] [Full Text] [Related]
31. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review. Zhang W, Krafft PR, Wang T, Zhang JH, Li L, Tang J. Cell Transplant; 2019 Jun 29; 28(6):657-661. PubMed ID: 30666888 [Abstract] [Full Text] [Related]
33. Effects of monosialoganglioside GM1 in experimental models of ischemic brain damage. Lipartiti M, Lazzaro A, Zanoni R, Bonvento G, Mazzari S. Ital J Neurol Sci; 1991 Jun 29; 12(3 Suppl 11):11-3. PubMed ID: 1757215 [Abstract] [Full Text] [Related]
34. Treatment with GM1 ganglioside increases rat spinal cord indole content. Hadjiconstantinou M, Neff NH. Brain Res; 1986 Feb 26; 366(1-2):343-5. PubMed ID: 2421824 [Abstract] [Full Text] [Related]
35. Pentoxifylline attenuates TNF-α protein levels and brain edema following temporary focal cerebral ischemia in rats. Vakili A, Mojarrad S, Akhavan MM, Rashidy-Pour A. Brain Res; 2011 Mar 04; 1377():119-25. PubMed ID: 21219888 [Abstract] [Full Text] [Related]
36. Intraventricular pre-treatment with rAAV-VEGF induces intracranial hypertension and aggravates ischemic injury at the early stage of transient focal cerebral ischemia in rats. Li Z, Wang R, Li S, Wei J, Zhang Z, Li G, Dou W, Wei Y, Feng M. Neurol Res; 2008 Oct 04; 30(8):868-75. PubMed ID: 18534058 [Abstract] [Full Text] [Related]
38. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH. Proc Natl Acad Sci U S A; 1991 Dec 15; 88(24):11158-62. PubMed ID: 1763030 [Abstract] [Full Text] [Related]
39. Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat. Masada T, Hua Y, Xi G, Ennis SR, Keep RF. J Cereb Blood Flow Metab; 2001 Jan 15; 21(1):22-33. PubMed ID: 11149665 [Abstract] [Full Text] [Related]
40. Hyperbaric oxygenation mitigates focal cerebral injury and reduces striatal dopamine release in a rat model of transient middle cerebral artery occlusion. Yang ZJ, Camporesi C, Yang X, Wang J, Bosco G, Lok J, Gorji R, Schelper RL, Camporesi EM. Eur J Appl Physiol; 2002 Jun 15; 87(2):101-7. PubMed ID: 12070618 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]